The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience
BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized. STUDY DESIGN...
Gespeichert in:
Veröffentlicht in: | Transfusion (Philadelphia, Pa.) Pa.), 2009-03, Vol.49 (3), p.421-426 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 426 |
---|---|
container_issue | 3 |
container_start_page | 421 |
container_title | Transfusion (Philadelphia, Pa.) |
container_volume | 49 |
creator | Quillen, Karen Yau, Yu Ying Leitman, Susan F. |
description | BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized.
STUDY DESIGN AND METHODS: A computerized database containing records of 1198 granulocyte collections from 137 unrelated volunteer apheresis donors during a 13‐year period was retrospectively analyzed. Donors were categorized by age, sex, and cumulative number of granulocyte donations. Complete blood counts at baseline and after G‐CSF/dex stimulation were recorded. The outcome variables include the preprocedure absolute neutrophil count (preANC), which reflects G‐CSF/dex stimulation, and the granulocyte product yield per liter processed (BagGranYield/L).
RESULTS: Higher baseline ANC and platelet (PLT) counts were significantly associated with higher preANC while a larger number of prior granulocytapheresis procedures was associated with lower preANC. Total filgrastim dose (used in weight‐based dosing) did not significantly impact preANC or the granulocyte yield; weight‐based dosing at 5 µg per kg and a uniform 480‐µg dose produced equivalent preANC. PreANC and weight were the key determinants of granulocyte yield (BagGranYield/L).
CONCLUSION: Apheresis donors with higher baseline PLT counts and ANCs have higher ANCs after G‐CSF/dex stimulation; donor age, weight, and sex do not have a significant impact. A uniform G‐CSF dose of 480 µg is as effective as weight‐based dosing at 5 µg per kg. Donor ANC monitoring should be considered after serial granulocytapheresis procedures. |
doi_str_mv | 10.1111/j.1537-2995.2008.01997.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421027</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20407727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5727-f86976ad852396a0af7ec13a6b9e30b1569ef3747b0b4833a8e16c0d5d8351803</originalsourceid><addsrcrecordid>eNqNks9u1DAQxiMEoqXwCsgXuGWx4ySOOSChlhZEBYgu4mg5zmTXi2Nvbafd5R15J7x_tG1P4IttzTe_GXu-LEMET0habxYTUlGWF5xXkwLjZoIJ52yyepQdHwKPs2OMS5ITQouj7FkIC4xxwTF5mh0RjktccXac_ZnOAXUQwQ_aShsDcj2aeWlH49Q6AlprMB3SFhHCmwcR5awCG72MENLFGFAROtR7N6DRejByc71xZrQRwKPOWecDGlyrjf6dQrc6zlPtlRwgzmVwFpC03f0aecI6u85D1MOYeNrOUC9VdP4tkojQfA3SI1gtwWtI3TzPnvTSBHix30-yH-cfpqcf88uvF59O31_mqmIFy_um5qyWXVMVlNcSy56BIlTWLQeKW1LVHHrKStbitmwolQ2QWuGu6hpakQbTk-zdjrsc2wG63TcYsfR6kH4tnNTiYcTquZi5G0HLguCCJcDrPcC76xFCFIMOCoyRFtwYRF3zmjFc_lNYpEEytiU2O6HyLgQP_aEbgsXGNGIhNt4QG2-IjWnE1jRilVJf3n_NXeLeJUnwai-QQUnTpwEpHQ66ghS4oqS5-5ZbbWD93w2I6ffz7TEB8h1AhwirA0D6X6JmlFXi55cLcfbt7HNzNb0SnP4FqYrzlA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20407727</pqid></control><display><type>article</type><title>The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Quillen, Karen ; Yau, Yu Ying ; Leitman, Susan F.</creator><creatorcontrib>Quillen, Karen ; Yau, Yu Ying ; Leitman, Susan F.</creatorcontrib><description>BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized.
STUDY DESIGN AND METHODS: A computerized database containing records of 1198 granulocyte collections from 137 unrelated volunteer apheresis donors during a 13‐year period was retrospectively analyzed. Donors were categorized by age, sex, and cumulative number of granulocyte donations. Complete blood counts at baseline and after G‐CSF/dex stimulation were recorded. The outcome variables include the preprocedure absolute neutrophil count (preANC), which reflects G‐CSF/dex stimulation, and the granulocyte product yield per liter processed (BagGranYield/L).
RESULTS: Higher baseline ANC and platelet (PLT) counts were significantly associated with higher preANC while a larger number of prior granulocytapheresis procedures was associated with lower preANC. Total filgrastim dose (used in weight‐based dosing) did not significantly impact preANC or the granulocyte yield; weight‐based dosing at 5 µg per kg and a uniform 480‐µg dose produced equivalent preANC. PreANC and weight were the key determinants of granulocyte yield (BagGranYield/L).
CONCLUSION: Apheresis donors with higher baseline PLT counts and ANCs have higher ANCs after G‐CSF/dex stimulation; donor age, weight, and sex do not have a significant impact. A uniform G‐CSF dose of 480 µg is as effective as weight‐based dosing at 5 µg per kg. Donor ANC monitoring should be considered after serial granulocytapheresis procedures.</description><identifier>ISSN: 0041-1132</identifier><identifier>EISSN: 1537-2995</identifier><identifier>DOI: 10.1111/j.1537-2995.2008.01997.x</identifier><identifier>PMID: 19040597</identifier><identifier>CODEN: TRANAT</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adult ; Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Blood Donors ; Blood Platelets - cytology ; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Cell Separation - methods ; Dexamethasone - pharmacology ; Female ; Granulocyte Colony-Stimulating Factor - pharmacology ; Granulocytes - cytology ; Granulocytes - drug effects ; Humans ; Leukocyte Count ; Male ; Medical sciences ; Middle Aged ; Time Factors ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><ispartof>Transfusion (Philadelphia, Pa.), 2009-03, Vol.49 (3), p.421-426</ispartof><rights>2009 American Association of Blood Banks</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5727-f86976ad852396a0af7ec13a6b9e30b1569ef3747b0b4833a8e16c0d5d8351803</citedby><cites>FETCH-LOGICAL-c5727-f86976ad852396a0af7ec13a6b9e30b1569ef3747b0b4833a8e16c0d5d8351803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1537-2995.2008.01997.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1537-2995.2008.01997.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1416,27922,27923,45572,45573</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21205318$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19040597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quillen, Karen</creatorcontrib><creatorcontrib>Yau, Yu Ying</creatorcontrib><creatorcontrib>Leitman, Susan F.</creatorcontrib><title>The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience</title><title>Transfusion (Philadelphia, Pa.)</title><addtitle>Transfusion</addtitle><description>BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized.
STUDY DESIGN AND METHODS: A computerized database containing records of 1198 granulocyte collections from 137 unrelated volunteer apheresis donors during a 13‐year period was retrospectively analyzed. Donors were categorized by age, sex, and cumulative number of granulocyte donations. Complete blood counts at baseline and after G‐CSF/dex stimulation were recorded. The outcome variables include the preprocedure absolute neutrophil count (preANC), which reflects G‐CSF/dex stimulation, and the granulocyte product yield per liter processed (BagGranYield/L).
RESULTS: Higher baseline ANC and platelet (PLT) counts were significantly associated with higher preANC while a larger number of prior granulocytapheresis procedures was associated with lower preANC. Total filgrastim dose (used in weight‐based dosing) did not significantly impact preANC or the granulocyte yield; weight‐based dosing at 5 µg per kg and a uniform 480‐µg dose produced equivalent preANC. PreANC and weight were the key determinants of granulocyte yield (BagGranYield/L).
CONCLUSION: Apheresis donors with higher baseline PLT counts and ANCs have higher ANCs after G‐CSF/dex stimulation; donor age, weight, and sex do not have a significant impact. A uniform G‐CSF dose of 480 µg is as effective as weight‐based dosing at 5 µg per kg. Donor ANC monitoring should be considered after serial granulocytapheresis procedures.</description><subject>Adult</subject><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Blood Donors</subject><subject>Blood Platelets - cytology</subject><subject>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Cell Separation - methods</subject><subject>Dexamethasone - pharmacology</subject><subject>Female</subject><subject>Granulocyte Colony-Stimulating Factor - pharmacology</subject><subject>Granulocytes - cytology</subject><subject>Granulocytes - drug effects</subject><subject>Humans</subject><subject>Leukocyte Count</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Time Factors</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><issn>0041-1132</issn><issn>1537-2995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks9u1DAQxiMEoqXwCsgXuGWx4ySOOSChlhZEBYgu4mg5zmTXi2Nvbafd5R15J7x_tG1P4IttzTe_GXu-LEMET0habxYTUlGWF5xXkwLjZoIJ52yyepQdHwKPs2OMS5ITQouj7FkIC4xxwTF5mh0RjktccXac_ZnOAXUQwQ_aShsDcj2aeWlH49Q6AlprMB3SFhHCmwcR5awCG72MENLFGFAROtR7N6DRejByc71xZrQRwKPOWecDGlyrjf6dQrc6zlPtlRwgzmVwFpC03f0aecI6u85D1MOYeNrOUC9VdP4tkojQfA3SI1gtwWtI3TzPnvTSBHix30-yH-cfpqcf88uvF59O31_mqmIFy_um5qyWXVMVlNcSy56BIlTWLQeKW1LVHHrKStbitmwolQ2QWuGu6hpakQbTk-zdjrsc2wG63TcYsfR6kH4tnNTiYcTquZi5G0HLguCCJcDrPcC76xFCFIMOCoyRFtwYRF3zmjFc_lNYpEEytiU2O6HyLgQP_aEbgsXGNGIhNt4QG2-IjWnE1jRilVJf3n_NXeLeJUnwai-QQUnTpwEpHQ66ghS4oqS5-5ZbbWD93w2I6ffz7TEB8h1AhwirA0D6X6JmlFXi55cLcfbt7HNzNb0SnP4FqYrzlA</recordid><startdate>200903</startdate><enddate>200903</enddate><creator>Quillen, Karen</creator><creator>Yau, Yu Ying</creator><creator>Leitman, Susan F.</creator><general>Blackwell Publishing Inc</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200903</creationdate><title>The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience</title><author>Quillen, Karen ; Yau, Yu Ying ; Leitman, Susan F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5727-f86976ad852396a0af7ec13a6b9e30b1569ef3747b0b4833a8e16c0d5d8351803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Blood Donors</topic><topic>Blood Platelets - cytology</topic><topic>Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Cell Separation - methods</topic><topic>Dexamethasone - pharmacology</topic><topic>Female</topic><topic>Granulocyte Colony-Stimulating Factor - pharmacology</topic><topic>Granulocytes - cytology</topic><topic>Granulocytes - drug effects</topic><topic>Humans</topic><topic>Leukocyte Count</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Time Factors</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quillen, Karen</creatorcontrib><creatorcontrib>Yau, Yu Ying</creatorcontrib><creatorcontrib>Leitman, Susan F.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transfusion (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quillen, Karen</au><au>Yau, Yu Ying</au><au>Leitman, Susan F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience</atitle><jtitle>Transfusion (Philadelphia, Pa.)</jtitle><addtitle>Transfusion</addtitle><date>2009-03</date><risdate>2009</risdate><volume>49</volume><issue>3</issue><spage>421</spage><epage>426</epage><pages>421-426</pages><issn>0041-1132</issn><eissn>1537-2995</eissn><coden>TRANAT</coden><abstract>BACKGROUND: The combination of granulocyte–colony‐stimulating factor (G‐CSF [filgrastim]) and dexamethasone (G‐CSF/dex) is an effective granulocyte mobilization regimen, but the variables that affect donor neutrophil response and granulocyte collection yield are not well characterized.
STUDY DESIGN AND METHODS: A computerized database containing records of 1198 granulocyte collections from 137 unrelated volunteer apheresis donors during a 13‐year period was retrospectively analyzed. Donors were categorized by age, sex, and cumulative number of granulocyte donations. Complete blood counts at baseline and after G‐CSF/dex stimulation were recorded. The outcome variables include the preprocedure absolute neutrophil count (preANC), which reflects G‐CSF/dex stimulation, and the granulocyte product yield per liter processed (BagGranYield/L).
RESULTS: Higher baseline ANC and platelet (PLT) counts were significantly associated with higher preANC while a larger number of prior granulocytapheresis procedures was associated with lower preANC. Total filgrastim dose (used in weight‐based dosing) did not significantly impact preANC or the granulocyte yield; weight‐based dosing at 5 µg per kg and a uniform 480‐µg dose produced equivalent preANC. PreANC and weight were the key determinants of granulocyte yield (BagGranYield/L).
CONCLUSION: Apheresis donors with higher baseline PLT counts and ANCs have higher ANCs after G‐CSF/dex stimulation; donor age, weight, and sex do not have a significant impact. A uniform G‐CSF dose of 480 µg is as effective as weight‐based dosing at 5 µg per kg. Donor ANC monitoring should be considered after serial granulocytapheresis procedures.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>19040597</pmid><doi>10.1111/j.1537-2995.2008.01997.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-1132 |
ispartof | Transfusion (Philadelphia, Pa.), 2009-03, Vol.49 (3), p.421-426 |
issn | 0041-1132 1537-2995 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421027 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Blood Donors Blood Platelets - cytology Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis Bone marrow, stem cells transplantation. Graft versus host reaction Cell Separation - methods Dexamethasone - pharmacology Female Granulocyte Colony-Stimulating Factor - pharmacology Granulocytes - cytology Granulocytes - drug effects Humans Leukocyte Count Male Medical sciences Middle Aged Time Factors Transfusions. Complications. Transfusion reactions. Cell and gene therapy |
title | The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T05%3A16%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20determinants%20of%20granulocyte%20yield%20in%201198%20granulocyte%20concentrates%20collected%20from%20unrelated%20volunteer%20donors%20mobilized%20with%20dexamethasone%20and%20granulocyte-colony-stimulating%20factor:%20a%2013-year%20experience&rft.jtitle=Transfusion%20(Philadelphia,%20Pa.)&rft.au=Quillen,%20Karen&rft.date=2009-03&rft.volume=49&rft.issue=3&rft.spage=421&rft.epage=426&rft.pages=421-426&rft.issn=0041-1132&rft.eissn=1537-2995&rft.coden=TRANAT&rft_id=info:doi/10.1111/j.1537-2995.2008.01997.x&rft_dat=%3Cproquest_pubme%3E20407727%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20407727&rft_id=info:pmid/19040597&rfr_iscdi=true |